packagePembrolizumab
pembrolizumab
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Pembrolizumab is a monoclonal antibody that blocks PD-1 and is used to treat several cancers, including melanoma, lung, bladder, kidney, head and neck, and endometrial cancers. It is approved and widely used, including an authorised product in the European Union.
Summary written by glm-5.3-flash from Wikidata Q13896859 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | pembrolizumab |
| ATC codes: | L01FF02 |
| DrugBank: | DB09037 |
| Wikidata: | Q13896859 |
| molar mass: | 149000 g/mol (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |